drugset / Trial / NCT01321489

A Study to Evaluate a Possible Superiority Expressed by the Faster Onset of Action and the Efficacy and Safety of Sildenafil Citrate 20mg Sublingual Tablet in the Treatment of Erectile Dysfunction of Different Etiologies

NCT01321489

Phase 3 Unknown 78 enrolled Laboratório Teuto Brasileiro S/A
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the tolerability and safety of Sildenafil Citrate 20mg Sublingual tablet, as well as a possible superiority expressed by the faster onset of action compared to Viagra ® 50mg tablet Coated in erectile dysfunction.

Timeline

Start
2011-09
Primary completion
2012-01
Completion
2012-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sildenafil Unknown 20 mg Other
Comparator Sildenafil Unknown 50 mg Other

Indications